{"id":47992,"date":"2022-09-06T12:02:21","date_gmt":"2022-09-06T10:02:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/"},"modified":"2022-09-06T12:02:21","modified_gmt":"2022-09-06T10:02:21","slug":"s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/","title":{"rendered":"S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Singulator\u2122 100 System and components to be available through local distributor in Norway, Finland, Denmark and Sweden.<\/i>\n<\/p>\n<p>LIVERMORE, Calif.&#8211;(BUSINESS WIRE)&#8211;S2 Genomics, Inc. today announced that it has entered into a distribution agreement with Techtum Lab AB for the promotion, sales, and support of S2 Genomics\u2019 Singulator\u2122 100 System and associated products for single-cell genomics and cell biology applications in Norway, Finland, Denmark and Sweden.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220906005031\/en\/834457\/5\/S2G-Primary-Gradient.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220906005031\/en\/834457\/21\/S2G-Primary-Gradient.jpg\"><\/a><\/p>\n<p>\n\u201cThe Nordic region is experiencing significant growth across all areas of single cell genomics and cell biology spurring demand for improved single-cell preparation solutions,\u201d said Dr. Stevan Jovanovich, S2 Genomics\u2019 Chief Executive Officer. \u201cWe are excited to welcome Techtum as a key partner for S2 Genomics. Techtum is a premier supplier and partner for research and clinical laboratories in the Nordic region and expanding our commercialization efforts with them represents a significant milestone for S2 Genomics.\u201d\n<\/p>\n<p>\n\u201cThe strategic partnership with Techtum is in line with our goal to accelerate our growing global network of strategic partners. This partnership supports our mission to support single cell research by providing synergistic life science products and services,&#8221; said Dr. Ravi Vinayak, Vice President of global channel sales for S2 Genomics, in a statement.\n<\/p>\n<p>\nS2 Genomics\u2019 Singulator\u2122 100 system provides consistent isolation of single cells or nuclei from solid tissue samples, essential to producing high-quality single-cell data from difficult tissue types. The Singulator\u2122 100 system uses single-use disposable cartridges and proprietary reagents to automate tissue dissociation in a convenient workflow. In addition, the system allows users to create their own dissociation protocols, use their own reagents, and dissociate tissue at low temperature to minimize changes to cell transcriptomes.\n<\/p>\n<p>\nUlrica Karlsson, CEO of Techtum Lab AB, noted, \u201cWe are excited to be working with S2 to bring the Singulator System to market and expand our product portfolio for single cell genomics and cell biology applications. The Singulator can facilitate workflows for our customers working with a variety of sample types and applications, including clinical research.\u201d\n<\/p>\n<p>\n<b>About S2 Genomics, Inc<\/b>.\n<\/p>\n<p>\nS2 Genomics, founded in 2016, is a leading developer of laboratory automation solutions for processing solid tissues for single-cell applications. S2 Genomics\u2019 technology platforms integrate advanced fluidics, optics, and biochemistry to produce automated sample preparation solutions for single-cell sequencing and cell biology applications, enabling discovery and innovation in life science research, healthcare, and agriculture. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2FS2Genomics.com&amp;esheet=52848637&amp;newsitemid=20220906005031&amp;lan=en-US&amp;anchor=https%3A%2F%2FS2Genomics.com&amp;index=1&amp;md5=a37bb4469cfcb8f1431c97c15c547181\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/S2Genomics.com<\/a>.\n<\/p>\n<p>\nFor Research Use Only. Not for use in diagnostic procedures.\n<\/p>\n<p>\nS2 Genomics, the S2 Genomics logo, and Singulator are trademarks of S2 Genomics, Inc.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nDr. Ravi Vinayak, VP Global Channel Sales, S2 Genomics, <a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;&#58;In&#x71;&#x75;&#x69;&#x72;&#x69;&#101;&#115;&#64;s2&#x67;&#x65;&#x6e;&#x6f;&#x6d;&#105;&#99;&#115;&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#73;&#x6e;q&#117;&#x69;r&#105;&#x65;s&#64;&#x73;2&#103;&#x65;&#110;&#x6f;&#x6d;&#105;&#x63;&#x73;&#46;&#x63;o&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Singulator\u2122 100 System and components to be available through local distributor in Norway, Finland, Denmark and Sweden. LIVERMORE, Calif.&#8211;(BUSINESS WIRE)&#8211;S2 Genomics, Inc. today announced that it has entered into a distribution agreement with Techtum Lab AB for the promotion, sales, and support of S2 Genomics\u2019 Singulator\u2122 100 System and associated products for single-cell genomics and &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47992","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Singulator\u2122 100 System and components to be available through local distributor in Norway, Finland, Denmark and Sweden. LIVERMORE, Calif.&#8211;(BUSINESS WIRE)&#8211;S2 Genomics, Inc. today announced that it has entered into a distribution agreement with Techtum Lab AB for the promotion, sales, and support of S2 Genomics\u2019 Singulator\u2122 100 System and associated products for single-cell genomics and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-06T10:02:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220906005031\/en\/834457\/21\/S2G-Primary-Gradient.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia\",\"datePublished\":\"2022-09-06T10:02:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\\\/\"},\"wordCount\":438,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005031\\\/en\\\/834457\\\/21\\\/S2G-Primary-Gradient.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\\\/\",\"name\":\"S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005031\\\/en\\\/834457\\\/21\\\/S2G-Primary-Gradient.jpg\",\"datePublished\":\"2022-09-06T10:02:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005031\\\/en\\\/834457\\\/21\\\/S2G-Primary-Gradient.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005031\\\/en\\\/834457\\\/21\\\/S2G-Primary-Gradient.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/","og_locale":"en_US","og_type":"article","og_title":"S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia - Pharma Trend","og_description":"Singulator\u2122 100 System and components to be available through local distributor in Norway, Finland, Denmark and Sweden. LIVERMORE, Calif.&#8211;(BUSINESS WIRE)&#8211;S2 Genomics, Inc. today announced that it has entered into a distribution agreement with Techtum Lab AB for the promotion, sales, and support of S2 Genomics\u2019 Singulator\u2122 100 System and associated products for single-cell genomics and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-06T10:02:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220906005031\/en\/834457\/21\/S2G-Primary-Gradient.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia","datePublished":"2022-09-06T10:02:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/"},"wordCount":438,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220906005031\/en\/834457\/21\/S2G-Primary-Gradient.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/","url":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/","name":"S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220906005031\/en\/834457\/21\/S2G-Primary-Gradient.jpg","datePublished":"2022-09-06T10:02:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220906005031\/en\/834457\/21\/S2G-Primary-Gradient.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220906005031\/en\/834457\/21\/S2G-Primary-Gradient.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-distribution-agreement-with-techtum-lab-ab-to-serve-scandinavia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47992","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47992"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47992\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}